- Home
- GTBP vs SNES Comparison
GTBP vs SNES Comparison
Compare GTBP & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTBP | SNES |
|---|---|---|
| Founded | 1965 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 12.1M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GTBP | SNES |
|---|---|---|
| Price | $0.41 | $1.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 648.3K | 46.0K |
| Earning Date | 03-02-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.75 | ★ 77.99 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $600,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | N/A | $95.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 132.56 |
| 52 Week Low | $0.39 | $1.30 |
| 52 Week High | $3.73 | $5.99 |
Technical Indicators
Market Signals| Indicator | GTBP | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 38.54 |
| Support Level | $0.40 | $1.67 |
| Resistance Level | $0.59 | $2.26 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 23.79 | 0.00 |
Price Performance
Historical ComparisonAbout GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.